Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 26, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05502224). This is a study registration, not published results. Lead sponsor: Jules Bordet Institute. Recruitment status: TERMINATED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 12 participants (ACTUAL). Conditions: Breast Cancer, Germ Cell Tumor. Interventions: OTHER: Ergospirometry. Primary outcome measures: Evaluate the feasibility of the specific fatigue management program , Through study completion, an average of 4 years. Brief summary: Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour